Real-world performance of transient elastography in assessing advanced fibrosis in Chinese patients with primary
Jia-Liang Chen1, Yi-Xin Hou1, Yao Liu1
1Center of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.
Background:
There is insufficient evidence on the evaluation of liver fibrosis in Asian individuals with primary biliary cholangitis (PBC) using vibration-controlled transient elastography (VCTE).
Aim:
To assess advanced fibrosis (AF) using liver stiffness measurement (LSM) in Chinese patients with PBC.
Methods:
In total, 277 Chinese patients diagnosed with PBC who underwent liver biopsy and VCTE were retrospectively included and categorized into the derivation and validation cohorts. The areas under the receiver operating characteristic curves (AUROCs) with 95% confidence intervals (CIs) were used to estimate the diagnostic accuracy of LSM for AF (Ludwig stage ≥ III). Multivariable analysis was performed using logistic regression.
Results:
In the derivation cohort, VCTE accurately detected patients with AF, achieving an AUROC of 0.93 (95%CI: 0.88-0.96). AF was independently predicted by LSM according to multivariable analysis. AF can be excluded and confirmed using LSM cutoffs of ≤ 10.0 and > 14.5 kPa, respectively, with a sensitivity of 0.91, negative predictive value of 0.93, specificity of 0.96, positive predictive value of 0.92, and an error rate of 7.5%. The accuracy of these values was validated in an independent cohort, achieving an AUROC of 0.97 (95%CI: 0.90-0.99) for AF with a sensitivity of 0.89, negative predictive value of 0.88, specificity of 0.95, positive predictive value of 0.94, and error rate of 9.0%. Compared with serum fibrosis markers, the AUROC of LSM was significantly higher in both the derivation and validation cohorts.
Conclusion:
VCTE has a high accuracy for assessing AF in Chinese patients with PBC in a real-world setting.
More Related Videos
Related Concept Videos
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test


